A new silica ingredient helps supplement and food formulators turn liquid, waxy, or oily active ingredients, such as omega-3 fatty acids and botanical extracts, into free-flowing powders.
Photo © iStockphoto.com
A new silica ingredient helps supplement and food formulators turn liquid, waxy, or oily active ingredients, such as omega-3 fatty acids and botanical extracts, into free-flowing powders. This eases incorporation of these challenging ingredients beyond conventional liquid or softgel capsules and into delivery formats such as hard capsules, tablets, stick packs, and sachets.
The new carrier solution, a patented food-grade silica called Syloid XDP F, was introduced this week at the Vitafoods Europe trade show by W.R. Grace & Co. (Columbia, MD). According to the company, Syloid XDP F “enables manufacturers to achieve improved blend uniformity compared to traditional mixing methods.” It also ensures that handling and downstream processing can be achieved without the need for solvents.
Yili to pilot Xampla’s microscopic natural biopolymer capsules for nutrient fortification
July 17th 2024Xampla, a manufacturer natural biopolymers, has announced a partnership with Yili Innovation Centre Europe to test and validate Xampla’s microscopic natural biopolymer capsules used to fortify a range of products with vitamins and nutrients.
Recent animal study finds that Lysoveta may help reduce neonatal brain injury
July 17th 2024A recent animal study found that lysophosphatidylcholine (LPC)-bound omega-3 long-chain polyunsaturated fatty acids (LCPUFAs), marketed as Lysoveta by Aker BioMarine, protected against neonatal hypoxic-ischemic (HI) brain injury in mice.
FDA and FTC issue more warning letters to copycat delta-8 THC food products
July 16th 2024The U.S. Food and Drug Administration and Federal Trade Commission have jointly issued warning letters to five companies for selling copycat food products containing delta-8 THC in violation of the Federal Food Drug and Cosmetic Act.
Krill oil supplementation raises Omega-3 Index of Lupus patients in recent study
July 16th 2024The study was conducted at 20 research centers in the United States by Aker BioMarine and the Lupus Clinical Investigators Network with oversight by Lupus Therapeutics, the clinical research affiliate of the Lupus Research Alliance.